Blueprint Medicines is a top-tier, publicly-traded (BPMC) biopharmaceutical company focused on discovering, developing and commercializing highly-selective kinase inhibitors for genomically defined diseases. Originally funded by Third Rock Ventures, the company has built a sophisticated genomics platform and a one-of-kind annotated compound collection which is delivering a pipeline of novel therapies. In just three years, four programs have been established in genomically defined cancers and one program in the rare genetic disease space.
Blueprint Medicines seeks an exceptional candidate for a Senior Clinical Study Manager - Clinical Operations. This position reports into the Director or Senior Director of Clinical Operations. The right candidate will possess an understanding of Clinical Operations for successful execution of multiple clinical trials primarily in oncology and hematology indications in various phases of development.
Responsibilities of this position involve the day to day management and oversight of clinical trials in collaboration with a dynamic Clinical Development team.
Specific Responsibilities include:
Education & Experience Requirements
WHO WE ARE:
Blueprint Medicines’ mission is to dramatically improve the lives of patients with genomically defined diseases. Our singular focus is to use our deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases to craft highly selective medicines aimed at eradicating these diseases.
We don’t think in small steps. We think in giant leaps.
We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
We know that what each and every one of us does matters and that our success depends on our ability to work together. We believe we are at our best as a company when our employees are thriving and foster a culture that provides opportunities to grow and develop professionally, while also having fun.